Pub Date : 2020-10-31DOI: 10.1201/9780429026638-20
C. von Arx, H. Gabra, C. Fotopoulou
{"title":"Uterine Cancer","authors":"C. von Arx, H. Gabra, C. Fotopoulou","doi":"10.1201/9780429026638-20","DOIUrl":"https://doi.org/10.1201/9780429026638-20","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78523127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-31DOI: 10.1201/9780429026638-13
R. Huddart, P. Kumar
{"title":"Bladder Cancer","authors":"R. Huddart, P. Kumar","doi":"10.1201/9780429026638-13","DOIUrl":"https://doi.org/10.1201/9780429026638-13","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80437693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-31DOI: 10.1201/9780429026638-15
H. Wasan, R. Adams
{"title":"Colorectal Cancer","authors":"H. Wasan, R. Adams","doi":"10.1201/9780429026638-15","DOIUrl":"https://doi.org/10.1201/9780429026638-15","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"71 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72746456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-31DOI: 10.1201/9780429026638-31
G. Pratt
{"title":"Multiple Myeloma","authors":"G. Pratt","doi":"10.1201/9780429026638-31","DOIUrl":"https://doi.org/10.1201/9780429026638-31","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"225 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80105278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-31DOI: 10.1201/9780429026638-21
G. Imseeh, Alexandra Taylor
{"title":"Cervical Cancer","authors":"G. Imseeh, Alexandra Taylor","doi":"10.1201/9780429026638-21","DOIUrl":"https://doi.org/10.1201/9780429026638-21","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"171 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84007051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-Hodgkin Lymphoma","authors":"P. Blombery, A. Bloor, D. Linch","doi":"10.1201/b17751-31","DOIUrl":"https://doi.org/10.1201/b17751-31","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"84 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76145227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Head and Neck Cancer","authors":"L. O’Toole, N. Stafford","doi":"10.1201/9780429026638-3","DOIUrl":"https://doi.org/10.1201/9780429026638-3","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80809876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-31DOI: 10.1201/9780429026638-28
T. Mughal
{"title":"Leukemias","authors":"T. Mughal","doi":"10.1201/9780429026638-28","DOIUrl":"https://doi.org/10.1201/9780429026638-28","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90581327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Germ-Cell Cancer of the Testis and Related Neoplasms","authors":"A. Kwan, D. Mazhar","doi":"10.1201/b17751-18","DOIUrl":"https://doi.org/10.1201/b17751-18","url":null,"abstract":"","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80434114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-31DOI: 10.1201/9780429026638-24
I. D. Francesco, S. Whittaker, S. Morris
Epidemiology About three quarters of non-melanoma skin cancers are basal cell carcinomas (basaliomas). These metastasise only in exceptional cases, especially when the immune system is weakened, and are therefore rarely life-threatening. However, they can grow into the surrounding tissue, e.g. into the bones, and thus lead to considerable restrictions in the quality of life. Almost a quarter of malignant, non-melanoma tumours of the skin are squamous cell carcinomas. About two thirds of these tumours occur on the head or neck. Among the rare forms is Merkel cell carcinoma, which belongs to the neuroendocrine tumours. In 2018, it is estimated that almost 200,000 people in Germany developed non-melanoma skin cancer for the first time, compared to around 1,000 deaths per year. After the introduction of skin cancer screening, the incidence increased significantly; the recent noticeable decline might also be explained by a declining registration rate. Even though internationally, the data availability is less good compared to malignant melanoma, it can be assumed that the incidence of the disease has increased significantly in the western industrial nations during the last decades. Risk factors Non-melanoma skin cancer occurs more often in people with light skin types than in people with darker skin types. The most important risk factor for non-melanoma skin cancer is a strong exposure of the skin to ultraviolet (UV) radiation, no matter if the source is natural (the sun) or artificial (a solarium). The risk of squamous cell carcinoma increases with the cumulative (lifetime) UV dose. In the case of basal cell carcinoma, the risk is probably also increased by intermittent (recurrent intensive) UV exposure. Those who have already developed non-melanoma skin cancer have an increased risk of developing it again. Actinic keratoses in particular increase the risk of squamous cell carcinoma. Non-melanoma skin cancer can also develop after many years of arsenic exposure, on radiation-damaged skin (for example after radiotherapy) or under immunosuppressive therapy, for example after an organ transplant. The statutory cancer screening programme provides for a skin examination every two years by a doctor with appropriate training (dermatologist, general practitioner) for men and women from the age of 35. Table 3.14.1 Overview of key epidemiological parameters for Germany, ICD-10 C44
{"title":"Non-Melanoma Skin Cancer","authors":"I. D. Francesco, S. Whittaker, S. Morris","doi":"10.1201/9780429026638-24","DOIUrl":"https://doi.org/10.1201/9780429026638-24","url":null,"abstract":"Epidemiology About three quarters of non-melanoma skin cancers are basal cell carcinomas (basaliomas). These metastasise only in exceptional cases, especially when the immune system is weakened, and are therefore rarely life-threatening. However, they can grow into the surrounding tissue, e.g. into the bones, and thus lead to considerable restrictions in the quality of life. Almost a quarter of malignant, non-melanoma tumours of the skin are squamous cell carcinomas. About two thirds of these tumours occur on the head or neck. Among the rare forms is Merkel cell carcinoma, which belongs to the neuroendocrine tumours. In 2018, it is estimated that almost 200,000 people in Germany developed non-melanoma skin cancer for the first time, compared to around 1,000 deaths per year. After the introduction of skin cancer screening, the incidence increased significantly; the recent noticeable decline might also be explained by a declining registration rate. Even though internationally, the data availability is less good compared to malignant melanoma, it can be assumed that the incidence of the disease has increased significantly in the western industrial nations during the last decades. Risk factors Non-melanoma skin cancer occurs more often in people with light skin types than in people with darker skin types. The most important risk factor for non-melanoma skin cancer is a strong exposure of the skin to ultraviolet (UV) radiation, no matter if the source is natural (the sun) or artificial (a solarium). The risk of squamous cell carcinoma increases with the cumulative (lifetime) UV dose. In the case of basal cell carcinoma, the risk is probably also increased by intermittent (recurrent intensive) UV exposure. Those who have already developed non-melanoma skin cancer have an increased risk of developing it again. Actinic keratoses in particular increase the risk of squamous cell carcinoma. Non-melanoma skin cancer can also develop after many years of arsenic exposure, on radiation-damaged skin (for example after radiotherapy) or under immunosuppressive therapy, for example after an organ transplant. The statutory cancer screening programme provides for a skin examination every two years by a doctor with appropriate training (dermatologist, general practitioner) for men and women from the age of 35. Table 3.14.1 Overview of key epidemiological parameters for Germany, ICD-10 C44","PeriodicalId":9541,"journal":{"name":"Cancer Research and Treatment : Official Journal of Korean Cancer Association","volume":"526 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77600398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：